Market Participants Recognise Kamada Ltd.'s (TLV:KMDA) Earnings Pushing Shares 25% Higher
Jan 11
Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedJan 30, 2025
DataAggregated Company Financials
Companies14
- 7D-5.3%
- 3M-0.1%
- 1Y-19.8%
- YTD2.7%
Over the last 7 days, the Biotech industry has dropped 5.3%, driven by Kamada declining 7.7%. Overall the industry is down 20% in 12 months. Earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 Jan 2025 | ₪2.2b | ₪684.4m | -₪228,452,892.00 | 15.1x | -9.5x | 3.2x |
| Sat, 28 Dec 2024 | ₪2.0b | ₪699.8m | -₪228,926,205.60 | 13.6x | -8.6x | 2.8x |
| Mon, 25 Nov 2024 | ₪2.0b | ₪685.6m | -₪267,239,014.70 | 13.4x | -7.5x | 2.9x |
| Wed, 23 Oct 2024 | ₪2.0b | ₪692.4m | -₪259,280,536.70 | 13.1x | -7.8x | 2.9x |
| Fri, 20 Sep 2024 | ₪2.1b | ₪687.8m | -₪258,213,380.90 | 13.2x | -8.1x | 3x |
| Sun, 18 Aug 2024 | ₪2.1b | ₪671.3m | -₪225,793,134.00 | 14.4x | -9.4x | 3.2x |
| Tue, 16 Jul 2024 | ₪2.1b | ₪624.3m | -₪323,244,822.60 | 17.1x | -6.6x | 3.4x |
| Thu, 13 Jun 2024 | ₪2.0b | ₪639.1m | -₪328,762,322.80 | 15.6x | -6.2x | 3.2x |
| Sat, 11 May 2024 | ₪2.2b | ₪601.2m | -₪387,363,906.20 | 16.8x | -5.6x | 3.6x |
| Mon, 08 Apr 2024 | ₪2.2b | ₪622.8m | -₪411,736,738.40 | 22.2x | -5.3x | 3.5x |
| Wed, 06 Mar 2024 | ₪2.5b | ₪572.1m | -₪360,696,827.60 | 63.8x | -7x | 4.4x |
| Fri, 02 Feb 2024 | ₪2.3b | ₪624.3m | -₪396,976,062.00 | 61.1x | -5.7x | 3.6x |
| Sun, 31 Dec 2023 | ₪2.4b | ₪619.3m | -₪394,524,920.00 | 63.1x | -6.1x | 3.9x |
| Tue, 28 Nov 2023 | ₪2.1b | ₪634.7m | -₪415,531,665.00 | 56.9x | -5.1x | 3.3x |
| Thu, 26 Oct 2023 | ₪2.0b | ₪653.7m | -₪429,901,124.00 | 71.2x | -4.6x | 3x |
| Sat, 23 Sep 2023 | ₪2.3b | ₪619.1m | -₪379,560,038.00 | 73.6x | -6.1x | 3.7x |
| Mon, 21 Aug 2023 | ₪1.9b | ₪615.3m | -₪339,188,433.00 | 66.2x | -5.6x | 3.1x |
| Wed, 19 Jul 2023 | ₪1.9b | ₪534.4m | -₪387,989,840.00 | n/a | -5x | 3.6x |
| Fri, 16 Jun 2023 | ₪1.9b | ₪529.3m | -₪385,290,271.00 | n/a | -5x | 3.6x |
| Sun, 14 May 2023 | ₪1.8b | ₪534.0m | -₪368,620,159.00 | n/a | -4.9x | 3.4x |
| Tue, 11 Apr 2023 | ₪1.6b | ₪609.0m | -₪424,030,920.00 | 2.4x | -3.9x | 2.7x |
| Thu, 09 Mar 2023 | ₪1.6b | ₪554.6m | -₪475,765,604.00 | 4.7x | -3.3x | 2.8x |
| Sat, 04 Feb 2023 | ₪1.6b | ₪536.0m | -₪463,564,079.00 | 4.7x | -3.5x | 3x |
| Mon, 02 Jan 2023 | ₪1.5b | ₪534.3m | -₪475,501,251.00 | 16.4x | -3.2x | 2.9x |
| Wed, 30 Nov 2022 | ₪1.7b | ₪516.2m | -₪472,694,014.00 | 18.3x | -3.6x | 3.3x |
| Fri, 28 Oct 2022 | ₪1.9b | ₪490.2m | -₪484,823,784.00 | 18.3x | -3.9x | 3.8x |
| Sun, 25 Sep 2022 | ₪1.9b | ₪491.0m | -₪485,378,779.00 | 18.5x | -3.9x | 3.9x |
| Tue, 23 Aug 2022 | ₪2.2b | ₪451.0m | -₪407,185,842.00 | 13x | -5.4x | 4.9x |
| Thu, 21 Jul 2022 | ₪2.1b | ₪492.1m | -₪400,017,406.00 | 12.6x | -5.2x | 4.2x |
| Sat, 18 Jun 2022 | ₪2.1b | ₪489.0m | -₪400,976,729.00 | 12.3x | -5.3x | 4.3x |
| Mon, 16 May 2022 | ₪2.3b | ₪478.6m | -₪490,134,338.00 | 13.8x | -4.8x | 4.9x |
| Wed, 13 Apr 2022 | ₪2.8b | ₪456.8m | -₪408,582,094.00 | 10x | -6.8x | 6.1x |
| Fri, 11 Mar 2022 | ₪2.8b | ₪464.3m | -₪225,454,422.00 | 7x | -12.3x | 6x |
| Sun, 06 Feb 2022 | ₪2.9b | ₪455.9m | -₪219,656,237.00 | 7x | -13.1x | 6.3x |
Price to Earnings Ratio
-13.1x
Current Industry PE
- Investors are pessimistic on the Israeli Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 3.7x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
- Losses for companies in the Biotechs industry have mostly stayed the same over the last three years.
- Meanwhile revenues for these companies have grown 15% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, losses haven't seen much improvement.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | -0.66% | |
| Healthcare | -2.99% | |
| Biotech | -5.31% | |
| Biotech | -5.31% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NXTG Nextage Therapeutics | ₪0.82 | 8.8% +₪4.3m | 96.9% | n/a | |
| BONS Bonus BioGroup | ₪0.17 | 1.8% +₪3.5m | -9.4% | PB23x | |
| PLNT PlantArc Bio | ₪2.81 | 37.6% +₪2.5m | -7.6% | PS2x | |
| MTLF Matricelf | ₪3.64 | 3.8% +₪2.2m | -10.0% | n/a | |
| CBI Clal Biotechnology Industries | ₪0.36 | 2.0% +₪1.1m | -4.5% | PS1749.8x |
